This is a paid press release. Contact the press release distributor directly with any inquiries.
AIS Healthcare Targeted Drug Delivery Named 2025 Pioneer in URAC’s Leaders in Performance Measurement Recognition Program
Business Wire
Mon, July 13, 2026 at 11:03 PM GMT+5:30
2 min read
DALLAS, July 13, 2026–(BUSINESS WIRE)–AIS Healthcare, a leading provider of targeted drug delivery and infusion care solutions, announced today that its Targeted Drug Delivery division has been recognized as a 2025 Pioneer in URAC’s Leaders in Performance Measurement (LPM) recognition program. This honor is awarded to URAC-accredited organizations who demonstrate leadership in measuring and improving the quality of patient care through performance measurement
The recognition follows URAC’s annual review of performance measurement data submitted by accredited organizations, reflecting AIS Healthcare’s continued commitment to evaluating and enhancing the care delivered to patients and healthcare providers
AIS Healthcare’s Targeted Drug Delivery division is focused on raising the bar for quality throughout the care continuum. From patient-specific compounded medications produced in state-of-the-art 503A compounding pharmacies, to comprehensive support services for patients and providers, AIS Healthcare goes beyond the expected to simultaneously enhance the care experience and advance quality standards at every step
“We are honored to be recognized by URAC as a 2025 Pioneer in Leaders in Performance Measurement,” said Simon Castellanos, Chief Executive Officer of AIS Healthcare. “This recognition reflects our ongoing commitment to quality, accountability, and continuous improvement, as well as our dedication to supporting providers and patients with high-quality care solutions.”
As a 2025 Pioneer in URAC’s Leaders in Performance Measurement program, AIS Healthcare will carry on using performance insights to strengthen quality initiatives, enhance patient experiences, and support healthcare providers with reliable, patient-centered targeted drug delivery services. The Targeted Drug Delivery division will continue to uphold these rigorous standards, use performance insights to guide improvements, and support the patients and healthcare providers who rely on AIS Healthcare for targeted drug delivery care.
Advancing quality. Improving lives
As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do
Learn more at aiscaregroup.com
Viewws/home/20260713335680/en/
Contacts
Simon Castellanos877.443.4006
